Suppr超能文献

仿生角膜基质通过结构修复和微环境调节实现无瘢痕性角膜伤口愈合。

Biomimetic Corneal Stroma for Scarless Corneal Wound Healing via Structural Restoration and Microenvironment Modulation.

机构信息

Eye Center, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Key Laboratory of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases, Zhejiang Provincial Engineering Institute on Eye Diseases, Hangzhou, 310009, P. R. China.

MOE Laboratory of Biosystems Homeostasis & Protection & College of Life Sciences-iCell Biotechnology Regenerative Biomedicine Laboratory, College of Life Sciences, Zhejiang University, Hangzhou, 310058, P. R. China.

出版信息

Adv Healthc Mater. 2024 Feb;13(5):e2302889. doi: 10.1002/adhm.202302889. Epub 2023 Nov 28.

Abstract

Corneal injury-induced stromal scarring causes the most common subtype of corneal blindness, and there is an unmet need to promote scarless corneal wound healing. Herein, a biomimetic corneal stroma with immunomodulatory properties is bioengineered for scarless corneal defect repair. First, a fully defined serum-free system is established to derive stromal keratocytes (hAESC-SKs) from a current Good Manufacturing Practice (cGMP)-grade human amniotic epithelial stem cells (hAESCs), and RNA-seq is used to validate the phenotypic transition. Moreover, hAESC-SKs are shown to possess robust immunomodulatory properties in addition to the keratocyte phenotype. Inspired by the corneal stromal extracellular matrix (ECM), a photocurable gelatin-based hydrogel is fabricated to serve as a scaffold for hAESC-SKs for bioengineering of a biomimetic corneal stroma. The rabbit corneal defect model is used to confirm that this biomimetic corneal stroma rapidly restores the corneal structure, and effectively reshapes the tissue microenvironment via proteoglycan secretion to promote transparency and inhibition of the inflammatory cascade to alleviate fibrosis, which synergistically reduces scar formation by ≈75% in addition to promoting wound healing. Overall, the strategy proposed here provides a promising solution for scarless corneal defect repair.

摘要

角膜损伤诱导的基质瘢痕导致最常见的角膜盲亚型,因此需要促进无瘢痕的角膜伤口愈合。在此,为了实现无瘢痕的角膜缺损修复,我们生物工程构建了一种具有免疫调节特性的仿生角膜基质。首先,我们建立了一个完全定义的无血清系统,从符合现行良好生产规范(cGMP)标准的人羊膜上皮干细胞(hAESCs)中获得基质角膜细胞(hAESC-SKs),并通过 RNA 测序验证了表型转变。此外,hAESC-SKs 除了具有角膜细胞表型外,还具有强大的免疫调节特性。受角膜基质细胞外基质(ECM)的启发,我们制备了一种光固化明胶基水凝胶作为 hAESC-SKs 的支架,用于仿生角膜基质的生物工程。我们使用兔角膜缺损模型证实,这种仿生角膜基质可快速恢复角膜结构,并通过蛋白聚糖分泌有效重塑组织微环境,从而促进透明度和抑制炎症级联反应,减轻纤维化,协同作用可使瘢痕形成减少约 75%,同时促进伤口愈合。总的来说,本研究提出的策略为无瘢痕的角膜缺损修复提供了一种有前途的解决方案。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验